Keene & Associates, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Keene & Associates, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$762,505
+8.4%
8,512
+3.0%
0.61%
+12.1%
Q2 2023$703,427
-4.0%
8,262
-6.7%
0.55%
-3.9%
Q1 2023$732,834
+6.1%
8,856
+0.8%
0.57%
-7.9%
Q4 2022$690,862
-8.3%
8,784
-13.7%
0.62%
-10.8%
Q3 2022$753,000
-4.3%
10,174
-15.7%
0.69%
-6.1%
Q2 2022$787,000
-8.1%
12,073
-10.8%
0.74%
+5.6%
Q1 2022$856,000
+37.6%
13,534
+15.5%
0.70%
+30.0%
Q4 2021$622,00011,7200.54%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders